Specialized expertise and customized solutions across 14 therapeutic centers of excellence, including oncology, GI/NASH, pediatrics, neurology and rare diseases.
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more"We strive to help improve outcomes and create a healthier, more sustainable world for people everywhere.
LEARN MOREReimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.
Research & Development OverviewGenerate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.
REAL WORLD EVIDENCE OVERVIEWElevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.
COMMERCIALIZATION OVERVIEWOrchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety, regulatory, quality and medical information.
COMPLIANCE OVERVIEWWhen your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.
TECHNOLOGIES OVERVIEWExplore our library of insights, thought leadership, and the latest topics & trends in healthcare.
DISCOVER INSIGHTSAn in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.
SEE LATEST REPORTSBy making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.
LEARN MOREBuilding on a rich history of developing AI for healthcare, IQVIA AI connects the right data, technology, and expertise to address the unique needs of healthcare. It's what we call Healthcare-grade AI.
LEARN MOREYour new expert analyst is here. Be at the forefront of data-driven decision-making with a new generative AI tool that enables you to interact with our products and solutions like never before. Get results you can trust, faster.
LEARN MOREThe IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.
LEARN MOREThe IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.
LEARN MOREIQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.
LEARN MOREEmpowering patients to personalize their healthcare and connecting them to caregivers has the potential to change the care delivery paradigm.
LEARN MORE"At IQVIA your potential has no limits. We thrive on bold ideas and fearless innovation. Join us in reimagining what’s possible.
VIEW ROLESOver the last decade a series of market and technological changes has challenged biopharma companies to reimagine how they engage with key customers – and even to reconsider which customers are most important. As physicians increasingly share their central role in treatment decisions with other, often institutional stakeholders, manufacturers' traditional commercial model risks diminishing returns. The treatment decision-making process is shifting as rapid digitization amplifies the explosion of healthcare data sources and information. While the personalization of treatment strategies shows tantalizing promise, it rests upon the integration of multiple sources of information, drawn from multiple stakeholders, to provide tailored, precise treatments. Companies must envision a different model, designed to work across a more complex, multi-stakeholder landscape, in which their own role must evolve.
For many companies, the involvement of multiple decision-makers presents a central challenge, since the prevailing commercial model rests upon the physician as its cornerstone. Today, manufacturers must navigate more complex ecosystems in which physicians play only one part. As these ecosystems develop around therapeutic areas, knitting together a diverse mix of stakeholders – payers, patients, hospital administrators, trial sites, registries, regulators, patient groups, and other data owners – how can companies ensure they remain a critical part of the value chain? Around which customers should companies organize? At what things must a company excel to demonstrate and deliver value to a complex, evolving stakeholder mix? At minimum, companies must confront the transformation of the value chain and secure a lasting role within it.
In this paper, we explore the principal pressures buffeting the industry’s commercial model and identify the elements necessary to succeed in this more complex environment. We also identify some notable risks, including some tempting strategic choices likely to fail.
By considering these drivers of change, companies can develop an operating model fit for purpose and quickly adaptable to the scope and speed of changes necessitated by an increasingly interconnected, data-rich customer ecosystem.
Specialized expertise and customized solutions across 14 therapeutic centers of excellence, including oncology, GI/NASH, pediatrics, neurology and rare diseases.